查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008876

核子医学设备市场报告：按产品、应用、最终用户和地区划分（2026-2034 年）

Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球核医设备市场规模达34亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到56亿美元，2026年至2034年的复合年增长率（CAGR）为5.34%。市场成长显着主要得益于对慢性疾病治疗和早期诊断需求的不断增长。此外，诊断影像技术的创新以及新兴市场和已开发国家对医疗保健领域（尤其是肿瘤学和神经病学领域）投资的增加，也进一步推动了市场的扩张。

核子医学设备市场趋势：

混合成像系统应用范围扩大

全球核子医学设备市场的一个显着趋势是混合影像解决方案（例如SPECT和PET）的日益普及。根据业界报告显示，2024年2月，印度PGIMER开发了一种先进的基于PET/CT的切片检查方法，该方法在诊断前列腺癌方面取得了95%的成功率。此类先进技术结合了解剖成像和功能成像，提高了心血管疾病和癌症等复杂疾病的诊断准确性。此外，这些系统的引入使医疗专业人员能够更准确地监测疾病进展，从而製定更有效的治疗策略。这种混合系统的发展趋势也凸显了对先进诊断工具日益增长的需求，推动了市场成长，并刺激了成像技术领域的进一步研发活动。

分子成像应用的扩展

根据核医设备市场研究报告，分子影像技术在全球市场正迅速发展。这一趋势主要归功于该技术能够对分子和细胞活动进行详细分析，有助于疾病的早期发现，尤其是在循环系统、肿瘤和神经系统疾病领域。此外，分子成像技术能够实现更精准的诊断，并支持整体的个人化治疗方法。例如，2024年2月，北美放射学会（RSNA）的研究人员开发了一种分子成像技术，在乳癌检测中具有高灵敏度，同时降低了假阳性率。具体而言，该技术的假阳性率仅16%，而MRI的伪阳性率则高达62%。此外，随着用于这些检测的放射性药物的效率不断提高，预计对分子成像的需求将大幅增长，并成为重要的市场趋势。

扩大放射性药物的使用范围。

根据《核子医学设备市场报告》，放射性药物的日益普及是全球市场的主要趋势之一。放射性药物在治疗和诊断应用中发挥着至关重要的作用，尤其是在某些慢性疾病和癌症的治疗中。此外，放射性药物研发的创新，例如减少副作用和增强标靶化，正在提高核医学治疗和影像的有效性。同时，医疗专业人员现在在治疗和诊断过程中依赖这些化合物，从而导致对能够高效利用这些先进药物的核医学设备的需求不断增长。例如，2024年8月，领先的製药公司礼来宣布将业务拓展至核同位素生产领域，以确保肿瘤治疗所需的放射性化合物的稳定供应。作为扩大策略的一部分，该公司向同位素供应商Ionetics投资了1000万美元。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球核子医学设备市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 单光子发射电脑断层扫描
    • 主要部分
      • 独立版
      • 杂交种
  • 正子断层扫描
    • 主要部分
      • 独立版
      • 杂交种
  • 平面闪烁显像

第七章 市场区隔：依应用领域划分

  • 神经病学
  • 肿瘤学
  • 循环系统
  • 其他的

第八章 市场区隔：依最终用户划分

  • 医院
  • 诊断影像中心
  • 学术研究机构
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Biodex Medical Systems Inc.（Mirion Technologies Inc.）
    • Cardinal Health Inc.
    • CMR Naviscan Corporation
    • DDD-Diagnostic A/S
    • Digirad Corporation
    • General Electric Company
    • Koninklijke Philips NV
    • Mediso Ltd.
    • Neusoft Corporation
    • Siemens AG
    • SurgicEye GmbH
    • Toshiba Corporation
Product Code: SR112026A4598

The global nuclear medicine equipment market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.34% during 2026-2034. The market is witnessing significant growth due to the increasing need for chronic diseases treatment and early diagnosis. Moreover, innovations in imaging technologies and heightening investments in healthcare sector, especially in oncology and neurology applications across both emerging and developed region, is further expanding the market.

NUCLEAR MEDICINE EQUIPMENT MARKET ANALYSIS:

  • Major Market Drivers: The market is principally driven by the magnifying prevalence of chronic disorders, such as cardiovascular disease and cancer, which demand upgraded treatment and diagnostic solutions. Moreover, rising demand for personalized treatment methods ad early disease detection, combined with technological innovations in imaging techniques, is fueling market expansion. In addition, developing healthcare infrastructure and elevating healthcare expenditure in developing as well as developed countries further foster the market's development. Furthermore, increasing awareness regarding the potential of nuclear medicine equipment, in enhancing patient outcomes has resulted to its amplified adoption across medical sector, establishing a profitable environment for the nuclear medicine equipment market growth.
  • Key Market Trends: Some of the key trends include technological advancements in imaging techniques and the intensifying adoption of hybrid imaging solutions. The incorporation of single photon emission computed tomography (SPECT) and positron emission tomography (PET) systems has improved the accuracy of diagnostic imaging, resulting in an enhanced treatment strategy and disease detection. Moreover, the market is also experiencing heightened research and development activities aimed at minimizing radiation exposure and improving imaging abilities. In addition, the magnifying emphasis on molecular imaging, combined with the innovation of advanced radioisotopes, is supporting the healthcare professionals in diagnosing diseases more precisely, further increasing the medicine equipment market demand significantly.
  • Geographical Trends: North America has emerged as the dominant region in the global nuclear medicine equipment market, mainly driven by resilient healthcare infrastructure and cutting-edge technology adoption. The United States, in particular, is a major contributor, with an elevated demand for nuclear imaging due to an increasing prevalence of chronic disorders and amplifying healthcare expenditure. Moreover, accelerating awareness regarding the benefits of nuclear medicine among patients as well as healthcare providers is significantly bolstering its adoption across numerous medical applications in the region. In addition, government campaigns endorsing research in nuclear medicine, along with the presence of key market players, further elevates the medicine equipment market value in North America.
  • Competitive Landscape: Some of the major market players in the nuclear medicine equipment industry include Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH, Toshiba Corporation, among many others.
  • Challenges and Opportunities: The market experiences challenges, such as strict regulatory standards and elevated equipment costs. The demand for trained and skilled personnels to operate sophisticated imaging equipment supplements operational challenges. However, there are substantial growth opportunities observed in developing countries with growing healthcare infrastructure and increasing investment in medical technologies. Moreover, innovations in radiopharmaceuticals and cost-effective imaging solutions further increase market prospects, establishing profitable opportunities for nuclear medicine equipment market expansion.

NUCLEAR MEDICINE EQUIPMENT MARKET TRENDS:

Increasing Adoption of Hybrid Imaging Systems

A notable trend in the global nuclear equipment market is the increasing adoption of hybrid imaging solutions such as SPECT and PET. As per industry reports, in February 2024, PGIMER, India, developed a cutting-edge PET/CT-based biopsy that exhibited 95% success rate for prostate cancer diagnosis. Such advanced technologies blend anatomical and functional imaging, offering improved precision in diagnosing complicated diseases such as cardiovascular disorders and cancer. In addition, the incorporation of such systems allows healthcare professionals to better monitor the progression of disease, resulting in a more efficient treatment strategy. Moreover, this inclination towards hybrid systems highlights the fueling demand for upgraded diagnostics tools, spurring market growth and fostering further research and development activities in imaging techniques.

Increasing Utilization Molecular Imaging

According to the nuclear medicine equipment market research report, molecular imaging is rapidly gaining momentum in the global market. This trend is primarily driven by the technology's capability to offer detailed analysis of molecular as well as cellular activity, which assists in early disease detection, especially in cardiology, oncology, and neurology. In addition, molecular imaging technologies are permitting more accurate diagnoses, supporting the overall customized treatment methods. For instance, in February 2024, researchers from the Radiological Society of North America developed a molecular imaging technology that offers high sensitivity for breast cancer detection with lowered chances of false positive results, i.e. 16% false positive rate in comparison to MRI's 62%. Moreover, as research continues to enhance the efficiency of radiopharmaceuticals leveraged in such procedures, the requirement for molecular imaging is anticipated to soar, establishing it as a critical trend in the market.

Heightened Adoption of Radiopharmaceuticals.

As per the nuclear medicine equipment market report, the amplifying adoption of radiopharmaceuticals is one of the key trends in the global market. Radiopharmaceuticals play a crucial role in therapeutic as well as diagnostic applications, especially for certain chronic disorders and cancer. Moreover, innovations in radiopharmaceutical development, such as lowered side effects and enhanced targeting agents, are improving the efficacy of nuclear therapy and imaging. In addition, healthcare providers are currently dependent of such compounds for treatment as well as diagnosis procedures, which is resultantly boosting the demand for nuclear medicine equipment that are efficient in leveraging such advanced agents. For instance, in August 2024, Eli Lily, a leading pharmaceutical company, announced its expansion in nuclear isotope production industry to secure a steady supply of radioactive compounds requisite for radiopharmaceutical oncology drugs. As an expansion strategy, the company invested USD 10 million into Ionetix, an isotope supplier.

NUCLEAR MEDICINE EQUIPMENT MARKET SEGMENTATION:

Breakup by Product:

  • Single-Photon Emission Computed Tomography
    • Standalone
    • Hybrid
  • Positron Emission Tomography
    • Standalone
    • Hybrid
  • Planar Scintigraphy

Single-photon emission computed tomography accounts for the majority of the market share

According to the nuclear medicine equipment market forecast, single-photon emission computed tomography (SPECT) is anticipated to sustain its dominance as the largest product segment. Standalone SPECT systems offer essential functional imaging, broadly leveraged in oncology, cardiology, and neurology. Whereas, hybrid SPECT systems merge both functional and anatomical imaging, providing enhanced diagnostics precision by offering more insightful images. Moreover, the incorporation of hybrid imaging systems in rapidly adopted, especially in complicated diagnostics conditions, further boosting market demand. In addition, the accuracy provided by hybrid SPECT systems is significantly fueling their adoption in emerging as well as developed healthcare markets. For instance, in March 2024, Spectrum Dynamics Medical announced the successful installation of its new, innovative, digital SPECT/CT VERITON-CT 400 at a European cancer center. It is a hybrid SPECT/CT that can efficiently detect and locate tumors in the body.

Breakup by Application:

  • Neurology
  • Oncology
  • Cardiology
  • Others

Oncology holds the largest share of the industry

As per the nuclear medicine equipment market overview, oncology represents the dominant application segment, majorly due to the increasing demand for nuclear imaging technologies such as SPECT and PET in cancer treatment as well as diagnosis. Such systems facilitate the early detection of cancerous tissues and the observation of treatment efficiency through accurate molecular imaging. In addition, the heightening prevalence of cancer worldwide, combined with advancements in radiopharmaceuticals and nuclear medicine, continues to bolster the demand for oncology-specific imaging equipment, establishing oncology as a major growth segment in the global nuclear medicine market. According to the World Health Organization, around 1 in 5 individuals are detected with cancer in their lifetime, while around 1 in 12 women and 1 in men die from this disease.

Breakup by End User:

  • Hospitals
  • Imaging Centers
  • Academic and Research Institutes
  • Others

Hospitals represent the leading market segment

Hospitals are the largest end-user segment that significantly contributes to the nuclear medicine equipment market revenue. As healthcare institutions with the robust infrastructure to maintain the sophisticated therapeutic and diagnostic procedures, hospitals rapidly dependent on cutting-edge imaging technologies such as PET and SPECT for precise treatment as well as diagnosis. In addition, the incorporation of nuclear medicine equipment into hospital ecosystem is requisite for enhancing patient care and outcome, especially in neurology, oncology, and cardiology. Moreover, the magnifying adoption of innovative nuclear imaging technologies and heightening investments in hospital-based imaging centers are bolstering growth within this crucial market segment.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest nuclear medicine equipment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nuclear medicine equipment.

North America has emerged as the leading regional market in, majorly driven by its robust healthcare infrastructure, early adoption of cutting-edge technologies and elevated healthcare expenditure. The United States, particularly, is at the forefront chiefly due to the high prevalence of chronic disorders such cardiovascular diseases and cancer, which accelerate the demand for nuclear imaging significantly. According to the National Cancer Institute, it is estimated that in 2024 total 2,001,140 new cancer cases will be diagnosed in the U.S., and around 611,720 individuals will die from this disease. In addition, government funds for research and development, coupled with the presence of key industry players, further fortifies North America's dominance in the global nuclear medicine equipment market.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nuclear medicine equipment industry include Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH, and Toshiba Corporation. ()
  • The market is represented by fierce competition among key companies such that are currently emphasizing on strategic acquisitions, partnerships, and product innovation, to sustain their market dominance. For instance, in June 2024, QEII Health Sciences Center of Nova Scotia Health acquired GE Healthcare's StarGuide SPECT/CT equipment. This was a USD 6 million project, co-funded by both Nova Scotia and QEII, and improves diagnostic accuracy for heart diseases and cancer. In addition, technological advancements in radiopharmaceutical development and hybrid imaging systems significantly fuel competition, as key players are actively striving to improve their diagnostic precision and enhance patient outcomes. The competitive landscape is further steered by elevating investments in research and technological innovations, consequently contributing to the optimistic nuclear medicine equipment market outlook.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global nuclear medicine equipment market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine equipment market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine equipment market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine equipment market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine equipment market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine equipment market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the nuclear medicine equipment market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global nuclear medicine equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Single-Photon Emission Computed Tomography
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Standalone
      • 6.1.2.2 Hybrid
    • 6.1.3 Market Forecast
  • 6.2 Positron Emission Tomography
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Standalone
      • 6.2.2.2 Hybrid
    • 6.2.3 Market Forecast
  • 6.3 Planar Scintigraphy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Imaging Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biodex Medical Systems Inc. (Mirion Technologies Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Cardinal Health Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CMR Naviscan Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 DDD-Diagnostic A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Digirad Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Mediso Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neusoft Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SurgicEye GmbH
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Toshiba Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nuclear Medicine Equipment Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Equipment Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Nuclear Medicine Equipment Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Nuclear Medicine Equipment Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Nuclear Medicine Equipment Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Nuclear Medicine Equipment Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Nuclear Medicine Equipment Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Nuclear Medicine Equipment (Neurology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Nuclear Medicine Equipment (Neurology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Nuclear Medicine Equipment (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Nuclear Medicine Equipment (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Nuclear Medicine Equipment (Cardiology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Nuclear Medicine Equipment (Cardiology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Nuclear Medicine Equipment (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Nuclear Medicine Equipment (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Nuclear Medicine Equipment (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Nuclear Medicine Equipment (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Nuclear Medicine Equipment (Imaging Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Nuclear Medicine Equipment (Imaging Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Nuclear Medicine Equipment (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Nuclear Medicine Equipment (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Nuclear Medicine Equipment Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Nuclear Medicine Equipment Industry: SWOT Analysis
  • Figure 80: Global: Nuclear Medicine Equipment Industry: Value Chain Analysis
  • Figure 81: Global: Nuclear Medicine Equipment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Equipment Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Nuclear Medicine Equipment Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Nuclear Medicine Equipment Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Equipment Market: Key Players